MPS IIIA

Clinical trials for MPS IIIA explained in plain language.

Never miss a new study

Get alerted when new MPS IIIA trials appear

Sign up with your email to follow new studies for MPS IIIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

One-Time gene therapy injection aims to halt devastating childhood disease

Disease control Recruiting now

This study is testing a one-time gene therapy called UX111 for children with Sanfilippo Syndrome Type A, a rare and severe genetic disorder. The therapy involves a single intravenous injection designed to deliver a working copy of a missing gene, with the goal of slowing or stopp…

Matched conditions: MPS IIIA

Phase: PHASE2, PHASE3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control

Last updated Mar 19, 2026 14:56 UTC

MPS IIIA

Get alerted when new MPS IIIA trials appear

One-Time gene therapy injection aims to halt devastating childhood disease